This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Esteve Pharmaceuticals, S.a., Universität Autonoma De Barcelona. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 34 
1 out of 49 
Years Active: 2022
Title: Carles Roca Lecha: Innovating Treatments for Lysosomal Storage Disorders
Introduction
Carles Roca Lecha is an innovative inventor based in Badalona, Spain. He has made significant contributions to the field of biotechnology, particularly in the treatment of lysosomal storage disorders. With a unique focus on adeno-associated virus vectors, his work stands at the intersection of pharmaceutical science and genetic research.
Latest Patents
One of Carles Roca Lecha's notable achievements includes the patent for "Adeno-associated virus vectors for the treatment of mucopolysaccharidoses." This invention provides groundbreaking adeno-associated virus-derived vectors and pharmaceutical compositions specifically designed for the treatment of mucopolysaccharidoses Type IIID. His research addresses critical needs in the treatment of lysosomal storage disorders, showcasing his innovative approach to complex medical challenges.
Career Highlights
Throughout his career, Carles has worked at reputable institutions, enhancing his expertise and influence in the biotechnology sector. He has held positions at Esteve Pharmaceuticals, S.A., where he contributed to pharmaceutical development, and at the Universitat Autònoma de Barcelona, engaging in academic research that bridges education and innovation.
Collaborations
In his journey as an inventor, Carles Roca Lecha has collaborated with notable professionals in the field, including Virginia A. Haurigot-Mendonça and Fàtima Bosch Tubert. These partnerships reflect the collaborative spirit essential for driving forward advancements in medical science and biotechnology.
Conclusion
Carles Roca Lecha exemplifies the impact of innovation in healthcare through his dedicated work on adeno-associated virus vectors. His patent not only represents a significant milestone in treating serious conditions like mucopolysaccharidoses but also emphasizes the importance of collaboration and research in transforming ideas into life-changing solutions. As he continues to explore new frontiers in biotechnology, his contributions remain vital to the ongoing quest for effective treatments for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile